Evaluation of Diabetic Foot Wound Healing Using Hydrogel/Nano Silver-based Dressing vs. Traditional Dressing
1 other identifier
interventional
30
1 country
1
Brief Summary
Background: The wound dressings perform a crucial role in the cutaneous wounds' management due to their ability to protect wounds and promote dermal and epidermal tissue regeneration. Objective: the aim of the present study to evaluate the effectiveness of using hydrogel/nano silver-based dressing vs. traditional dressing on diabetic foot wound healing. Approach: Sixty patients with type-2 diabetes hospitalized for diabetic foot wound treatment were recruited from selected Surgical departments at Kasr Al-Aini university hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedFirst Submitted
Initial submission to the registry
April 1, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedApril 8, 2021
April 1, 2021
3 months
April 1, 2021
April 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the percentage of a reduction rate of the diabetic foot ulcer after intervention
assess of diabetic foot ulcers size "sq mm"
3 Weeks
Study Arms (1)
hydrogel/nano silver-based dressing
EXPERIMENTALhydrogel/nano silver-based dressing
Interventions
compare the effectiveness of using hydrogel/nano silver-based dressing vs. traditional dressing on diabetic foot wound healing.
Eligibility Criteria
You may qualify if:
- Diabetes Type I and Type II patient with diabetic foot ulcer age ranged 35-55 years old Willing to participate
You may not qualify if:
- unwilling to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Magda Bayoumilead
Study Sites (1)
Cairo University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
April 1, 2021
First Posted
April 8, 2021
Study Start
January 3, 2019
Primary Completion
April 3, 2019
Study Completion
December 30, 2019
Last Updated
April 8, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share